Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Gu, YM; LaBell, R; O'Brien, DF; Saavedra, SS
   Quantitative studies of binding between synthetic galactosyl ceramide analogues and HIV-1 Gp120 at planar membrane surfaces
   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
   
   Y.M. Gu et al., "Quantitative studies of binding between synthetic galactosyl ceramide analogues and HIV-1 Gp120 at planar membrane surfaces", ANGEW CHEM, 40(12), 2001, pp. 2320
2. Turville, SG; Cameron, PU; Arthos, J; MacDonald, K; Clark, G; Hart, D; Cunningham, AL
   Bitter-sweet symphony: defining the role of dendritic cell gp120 receptorsin HIV infection
   JOURNAL OF CLINICAL VIROLOGY
   
   S.G. Turville et al., "Bitter-sweet symphony: defining the role of dendritic cell gp120 receptorsin HIV infection", J CLIN VIRO, 22(3), 2001, pp. 229-239
3. Schweighardt, B; Atwood, WJ
   Virus receptors in the human central nervous system
   JOURNAL OF NEUROVIROLOGY
   
   B. Schweighardt e W.J. Atwood, "Virus receptors in the human central nervous system", J NEUROVIRO, 7(3), 2001, pp. 187-195
4. Overbaugh, J; Miller, AD; Eiden, MV
   Receptors and entry cofactors for retroviruses include single and multipletransmembrane-spanning proteins as well as newly described glycophosphatidylinositol-anchored and secreted proteins
   MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS
   
   J. Overbaugh et al., "Receptors and entry cofactors for retroviruses include single and multipletransmembrane-spanning proteins as well as newly described glycophosphatidylinositol-anchored and secreted proteins", MICRO M B R, 65(3), 2001, pp. 371
5. Chen, XN; Scala, G; Quinto, I; Liu, WM; Chun, TW; Justement, JS; Cohen, OJ; vanCott, TC; Iwanicki, M; Lewis, MG; Greenhouse, J; Barry, T; Venzon, D; Fauci, AS
   Protection of rhesus macaques against disease progression from pathogenic SHIV-89.6PD by vaccination with phage-displayed HIV-1 epitopes
   NATURE MEDICINE
   
   X.N. Chen et al., "Protection of rhesus macaques against disease progression from pathogenic SHIV-89.6PD by vaccination with phage-displayed HIV-1 epitopes", NAT MED, 7(11), 2001, pp. 1225-1231
6. Saha, K; Zhang, JC; Gupta, A; Dave, R; Yimen, M; Zerhouni, B
   Isolation of primary HIV-1 that target CD8(+) T Lymphocytes using CD8 as areceptor
   NATURE MEDICINE
   
   K. Saha et al., "Isolation of primary HIV-1 that target CD8(+) T Lymphocytes using CD8 as areceptor", NAT MED, 7(1), 2001, pp. 65-72
7. Piguet, V; Trono, D
   Living in oblivion: HIV immune evasion
   SEMINARS IN IMMUNOLOGY
   
   V. Piguet e D. Trono, "Living in oblivion: HIV immune evasion", SEMIN IMMUN, 13(1), 2001, pp. 51-57
8. Patton, HK; Chu, WJ; Hetherington, HP; den Hollander, J; Stewart, KE; Raper, JL; Shelton, BJ; Benveniste, EN; Benos, DJ
   Alkaline pH changes in the cerebellum of asymptomatic HIV-infected individuals
   NMR IN BIOMEDICINE
   
   H.K. Patton et al., "Alkaline pH changes in the cerebellum of asymptomatic HIV-infected individuals", NMR BIOMED, 14(1), 2001, pp. 12-18
9. Caffrey, M
   Model for the structure of the HIV gp41 ectodomain: insight into the intermolecular interactions of the gp41 loop
   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
   
   M. Caffrey, "Model for the structure of the HIV gp41 ectodomain: insight into the intermolecular interactions of the gp41 loop", BBA-MOL BAS, 1536(2-3), 2001, pp. 116-122
10. Zhang, YJ; Zhang, LQ; Ketas, T; Korber, BTM; Moore, JP
    HIV type 1 molecular clones able to use the Bonzo/STRL-33 coreceptor for virus entry
    AIDS RESEARCH AND HUMAN RETROVIRUSES
    
    Y.J. Zhang et al., "HIV type 1 molecular clones able to use the Bonzo/STRL-33 coreceptor for virus entry", AIDS RES H, 17(3), 2001, pp. 217-227
11. Losman, B; Bolmstedt, A; Schonning, K; Bjorndal, A; Westin, C; Fenyo, EM; Olofsson, S
    Protection of neutralization epitopes in the V3 loop of oligomeric human immunodeficiency virus type I glycoprotein 120 by N-linked oligosaccharides in the V1 region
    AIDS RESEARCH AND HUMAN RETROVIRUSES
    
    B. Losman et al., "Protection of neutralization epitopes in the V3 loop of oligomeric human immunodeficiency virus type I glycoprotein 120 by N-linked oligosaccharides in the V1 region", AIDS RES H, 17(11), 2001, pp. 1067-1076
12. Begovac, J; Lepej, SZ; Kniewald, T; Lisic, M
    Biological, epidemiological and clinical basis of understanding human immunodeficiency virus infection
    COLLEGIUM ANTROPOLOGICUM
    
    J. Begovac et al., "Biological, epidemiological and clinical basis of understanding human immunodeficiency virus infection", COLL ANTROP, 25(1), 2001, pp. 111-126
13. Jason, J; Inge, KL
    Modulation of CD8 and CD3 by HIV or HIV antigens
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY
    
    J. Jason e K.L. Inge, "Modulation of CD8 and CD3 by HIV or HIV antigens", SC J IMMUN, 53(3), 2001, pp. 259-267
14. Ruff, MR; Melendez-Guerrero, LM; Yang, QE; Ho, WZ; Mikovits, JW; Pert, CB; Ruscetti, FA
    Peptide T inhibits HIV-1 infection mediated by the chemokine receptor-5 (CCR5)
    ANTIVIRAL RESEARCH
    
    M.R. Ruff et al., "Peptide T inhibits HIV-1 infection mediated by the chemokine receptor-5 (CCR5)", ANTIVIR RES, 52(1), 2001, pp. 63-75
15. LaBranche, CC; Galasso, G; Moore, JP; Bolognesi, DP; Hirsch, MS; Hammer, SM
    HIV fusion and its inhibition
    ANTIVIRAL RESEARCH
    
    C.C. LaBranche et al., "HIV fusion and its inhibition", ANTIVIR RES, 50(2), 2001, pp. 95-115
16. Ondoa, P; Davis, D; Willems, B; Heyndrickx, L; Kestens, L; van der Berg, I; Coppens, S; Janssens, W; Heeney, J; van der Groen, G
    Genetic variability of the V1 and V2 env domains of SIVcpz-ant and neutralization pattern of plasma viruses in a chimpanzee infected naturally
    JOURNAL OF MEDICAL VIROLOGY
    
    P. Ondoa et al., "Genetic variability of the V1 and V2 env domains of SIVcpz-ant and neutralization pattern of plasma viruses in a chimpanzee infected naturally", J MED VIROL, 65(4), 2001, pp. 765-776
17. Eckert, DM; Kim, PS
    Mechanisms of viral membrane fusion and its inhibition
    ANNUAL REVIEW OF BIOCHEMISTRY
    
    D.M. Eckert e P.S. Kim, "Mechanisms of viral membrane fusion and its inhibition", ANN R BIOCH, 70, 2001, pp. 777-810
18. Power, C; Johnson, RT
    Neuroimmune and neurovirological aspects of human immunodeficiency virus infection
    ADVANCES IN VIRUS RESEARCH, VOL 56
    
    C. Power e R.T. Johnson, "Neuroimmune and neurovirological aspects of human immunodeficiency virus infection", ADV VIRUS R, 56, 2001, pp. 389-433
19. Barry, JD; McCulloch, R
    Antigenic variation in trypanosomes: Enhanced phenotypic variation in a eukaryotic parasite
    ADVANCES IN PARASITOLOGY, VOL 49
    
    J.D. Barry e R. McCulloch, "Antigenic variation in trypanosomes: Enhanced phenotypic variation in a eukaryotic parasite", ADV PARASIT, 49, 2001, pp. 1-70
20. Frost, SDW; Gunthard, HF; Wong, JK; Havlir, D; Richman, DD; Brown, AJL
    Evidence for positive selection driving the evolution of HIV-1 env under potent antiviral therapy
    VIROLOGY
    
    S.D.W. Frost et al., "Evidence for positive selection driving the evolution of HIV-1 env under potent antiviral therapy", VIROLOGY, 284(2), 2001, pp. 250-258
21. Bolmstedt, AJ; O'Keefe, BR; Shenoy, SR; Mcmahon, JB; Boyd, MR
    HIV-inhibitory natural products part 71 - Cyanovirin-N defines a new classof antiviral agent targeting N-linked, high-mannose glycans in an oligosaccharide-specific manner
    MOLECULAR PHARMACOLOGY
    
    A.J. Bolmstedt et al., "HIV-inhibitory natural products part 71 - Cyanovirin-N defines a new classof antiviral agent targeting N-linked, high-mannose glycans in an oligosaccharide-specific manner", MOLEC PHARM, 59(5), 2001, pp. 949-954
22. Means, RE; Matthews, T; Hoxie, JA; Malim, MH; Kodama, T; Desrosiers, RC
    Ability of the v3 loop of simian immunodeficiency virus to serve as a target for antibody-mediated neutralization: Correlation of neutralization sensitivity, growth in macrophages, and decreased dependence on CD4
    JOURNAL OF VIROLOGY
    
    R.E. Means et al., "Ability of the v3 loop of simian immunodeficiency virus to serve as a target for antibody-mediated neutralization: Correlation of neutralization sensitivity, growth in macrophages, and decreased dependence on CD4", J VIROLOGY, 75(8), 2001, pp. 3903-3915
23. Kolchinsky, P; Kiprilov, E; Bartley, P; Rubinstein, R; Sodroski, J
    Loss of a single N-linked glycan allows CD4-independent human immunodeficiency virus type 1 infection by altering the position of the gp120 V1/V2 variable loops
    JOURNAL OF VIROLOGY
    
    P. Kolchinsky et al., "Loss of a single N-linked glycan allows CD4-independent human immunodeficiency virus type 1 infection by altering the position of the gp120 V1/V2 variable loops", J VIROLOGY, 75(7), 2001, pp. 3435-3443
24. York, J; Follis, KE; Trahey, M; Nyambi, PN; Zolla-Pazner, S; Nunberg, JH
    Antibody binding and neutralization of primary and T-cell line-adapted isolates of human immunodeficiency virus type 1
    JOURNAL OF VIROLOGY
    
    J. York et al., "Antibody binding and neutralization of primary and T-cell line-adapted isolates of human immunodeficiency virus type 1", J VIROLOGY, 75(6), 2001, pp. 2741-2752
25. Kolchinsky, P; Kiprilov, E; Sodroski, J
    Increased neutralization sensitivity of CD4-independent human immunodeficiency virus variants
    JOURNAL OF VIROLOGY
    
    P. Kolchinsky et al., "Increased neutralization sensitivity of CD4-independent human immunodeficiency virus variants", J VIROLOGY, 75(5), 2001, pp. 2041-2050
26. Spenlehauer, C; Kirn, A; Aubertin, AM; Moog, C
    Antibody-mediated neutralization of primary human immunodeficiency virus type 1 isolates: Investigation of the mechanism of inhibition
    JOURNAL OF VIROLOGY
    
    C. Spenlehauer et al., "Antibody-mediated neutralization of primary human immunodeficiency virus type 1 isolates: Investigation of the mechanism of inhibition", J VIROLOGY, 75(5), 2001, pp. 2235-2245
27. Beaumont, T; van Nuenen, A; Broersen, S; Blattner, WA; Lukashov, VV; Schuitemaker, H
    Reversal of human immunodeficiency virus type 1 IIIB to a neutralization-resistant phenotype in an accidentally infected laboratory worker with a progressive clinical course
    JOURNAL OF VIROLOGY
    
    T. Beaumont et al., "Reversal of human immunodeficiency virus type 1 IIIB to a neutralization-resistant phenotype in an accidentally infected laboratory worker with a progressive clinical course", J VIROLOGY, 75(5), 2001, pp. 2246-2252
28. Broussard, SR; Staprans, SI; White, R; Whitehead, EM; Feinberg, MB; Allan, JS
    Simian immunodeficiency virus replicates to high levels in naturally infected African green monkeys without inducing immunologic or neurologic disease
    JOURNAL OF VIROLOGY
    
    S.R. Broussard et al., "Simian immunodeficiency virus replicates to high levels in naturally infected African green monkeys without inducing immunologic or neurologic disease", J VIROLOGY, 75(5), 2001, pp. 2262-2275
29. Zwick, MB; Labrijn, AF; Wang, M; Spenlehauer, C; Saphire, EO; Binley, JM; Moore, JP; Stiegler, G; Katinger, H; Burton, DR; Parren, PWHI
    Broadly neutralizing antibodies targeted to the membrane-proximal externalregion of human immunodeficiency virus type 1 glycoprotein gp41
    JOURNAL OF VIROLOGY
    
    M.B. Zwick et al., "Broadly neutralizing antibodies targeted to the membrane-proximal externalregion of human immunodeficiency virus type 1 glycoprotein gp41", J VIROLOGY, 75(22), 2001, pp. 10892-10905
30. Shankarappa, R; Chatterjee, R; Learn, GH; Neogi, D; Ding, M; Roy, P; Ghosh, A; Kingsley, L; Harrison, L; Mullins, JI; Gupta, P
    Human immunodeficiency virus type 1 env sequences from Calcutta in easternIndia: Identification of features that distinguish subtype C sequences in India from other subtype C sequences
    JOURNAL OF VIROLOGY
    
    R. Shankarappa et al., "Human immunodeficiency virus type 1 env sequences from Calcutta in easternIndia: Identification of features that distinguish subtype C sequences in India from other subtype C sequences", J VIROLOGY, 75(21), 2001, pp. 10479-10487
31. Chen, CH; Jin, L; Zhu, CB; Holz-Smith, S; Matthews, TJ
    Induction and characterization of neutralizing antibodies against a human immunodeficiency virus type 1 primary isolate
    JOURNAL OF VIROLOGY
    
    C.H. Chen et al., "Induction and characterization of neutralizing antibodies against a human immunodeficiency virus type 1 primary isolate", J VIROLOGY, 75(14), 2001, pp. 6700-6704
32. Moore, JP; Parren, PWHI; Burton, DR
    Genetic subtypes, humoral immunity, and human immunodeficiency virus type 1 vaccine development
    JOURNAL OF VIROLOGY
    
    J.P. Moore et al., "Genetic subtypes, humoral immunity, and human immunodeficiency virus type 1 vaccine development", J VIROLOGY, 75(13), 2001, pp. 5721-5729
33. Montefiori, DC; Safrit, JT; Lydy, SL; Barry, AP; Bilska, M; Vo, HTT; Klein, M; Tartaglia, J; Robinson, HL; Rovinski, B
    Induction of neutralizing antibodies and gag-specific cellular immune responses to an R5 primary isolate of human immunodeficiency virus type 1 in rhesus macaques
    JOURNAL OF VIROLOGY
    
    D.C. Montefiori et al., "Induction of neutralizing antibodies and gag-specific cellular immune responses to an R5 primary isolate of human immunodeficiency virus type 1 in rhesus macaques", J VIROLOGY, 75(13), 2001, pp. 5879-5890
34. Hewson, TJ; Logie, JJ; Simmonds, P; Howie, SEM
    A CCR5-dependent novel mechanism for type 1 HIV gp120 induced loss of macrophage cell surface CD4
    JOURNAL OF IMMUNOLOGY
    
    T.J. Hewson et al., "A CCR5-dependent novel mechanism for type 1 HIV gp120 induced loss of macrophage cell surface CD4", J IMMUNOL, 166(8), 2001, pp. 4835-4842
35. Dragic, T
    An overview of the determinants of CCR5 and CXCR4 co-receptor function
    JOURNAL OF GENERAL VIROLOGY
    
    T. Dragic, "An overview of the determinants of CCR5 and CXCR4 co-receptor function", J GEN VIROL, 82, 2001, pp. 1807-1814
36. Babcock, GJ; Mirzabekov, T; Wojtowicz, W; Sodroski, J
    Ligand binding characteristics of CXCR4 incorporated into paramagnetic proteoliposomes
    JOURNAL OF BIOLOGICAL CHEMISTRY
    
    G.J. Babcock et al., "Ligand binding characteristics of CXCR4 incorporated into paramagnetic proteoliposomes", J BIOL CHEM, 276(42), 2001, pp. 38433-38440
37. Bes, C; Briant-Longuet, L; Cerruti, M; DeBerardinis, P; Devauchelle, G; Devaux, C; Granier, C; Chardes, T
    Efficient CD4 binding and immunosuppressive properties of the 13B8.2 monoclonal antibody are displayed by its CDR-H1-derived peptide CB1
    FEBS LETTERS
    
    C. Bes et al., "Efficient CD4 binding and immunosuppressive properties of the 13B8.2 monoclonal antibody are displayed by its CDR-H1-derived peptide CB1", FEBS LETTER, 508(1), 2001, pp. 67-74
38. Zeder-Lutz, G; Hoebeke, J; Van Regenmortel, MHV
    Differential recognition of epitopes present on monomeric and oligomeric forms of gp160 glycoprotein of human immunodeficiency virus type 1 by human monoclonal antibodies
    EUROPEAN JOURNAL OF BIOCHEMISTRY
    
    G. Zeder-Lutz et al., "Differential recognition of epitopes present on monomeric and oligomeric forms of gp160 glycoprotein of human immunodeficiency virus type 1 by human monoclonal antibodies", EUR J BIOCH, 268(10), 2001, pp. 2856-2866
39. Veljkovic, V; Metlas, R; Jevtovic, D; Stringer, WW
    The role of passive immunization in HIV-positive patients - A case report
    CHEST
    
    V. Veljkovic et al., "The role of passive immunization in HIV-positive patients - A case report", CHEST, 120(2), 2001, pp. 662-666
40. Ley, SV; Baeschlin, DK; Dixon, DJ; Foster, AC; Ince, SJ; Priepke, HWM; Reynolds, DJ
    1,2-diacetals: A new opportunity for organic synthesis
    CHEMICAL REVIEWS
    
    S.V. Ley et al., "1,2-diacetals: A new opportunity for organic synthesis", CHEM REV, 101(1), 2001, pp. 53-80
41. Clapham, PR; McKnight, A
    HIV-1 receptors and cell tropism
    BRITISH MEDICAL BULLETIN
    
    P.R. Clapham e A. McKnight, "HIV-1 receptors and cell tropism", BR MED B, 58, 2001, pp. 43-59
42. Mansfield, KG; Veazey, RS; Hancock, A; Carville, A; Elliott, M; Lin, KC; Lackner, AA
    Induction of disseminated Mycobacterium avium in simian AIDS is dependent upon simian immunodeficiency virus strain and defective granuloma formation
    AMERICAN JOURNAL OF PATHOLOGY
    
    K.G. Mansfield et al., "Induction of disseminated Mycobacterium avium in simian AIDS is dependent upon simian immunodeficiency virus strain and defective granuloma formation", AM J PATH, 159(2), 2001, pp. 693-702
43. Conboy, JC; McReynolds, KD; Gervay-Hague, J; Saavedra, SS
    Gp120 binds cooperatively to several biologically relevant glycosphingolipids: Quantitative measurements at equilibrium by total internal reflection fluorescence microscopy
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
    
    J.C. Conboy et al., "Gp120 binds cooperatively to several biologically relevant glycosphingolipids: Quantitative measurements at equilibrium by total internal reflection fluorescence microscopy", ANGEW CHEM, 39(16), 2000, pp. 2882-2884
44. Blair, WS; Lin, PF; Meanwell, NA; Wallace, OB
    HIV-1 entry - an expanding portal for drug discovery
    DRUG DISCOVERY TODAY
    
    W.S. Blair et al., "HIV-1 entry - an expanding portal for drug discovery", DRUG DISC T, 5(5), 2000, pp. 183-194
45. Scully, C; Porter, S
    HIV topic update: oro-genital transmission of HIV
    ORAL DISEASES
    
    C. Scully e S. Porter, "HIV topic update: oro-genital transmission of HIV", ORAL DIS, 6(2), 2000, pp. 92-98
46. Dale, CJ; Kent, SJ
    Vaccines for HIV
    EXPERT OPINION ON THERAPEUTIC PATENTS
    
    C.J. Dale e S.J. Kent, "Vaccines for HIV", EXPERT OP T, 10(8), 2000, pp. 1179-1188
47. Burton, DR; Parren, PWHI
    Vaccines and the induction of functional antibodies: Time to look beyond the molecules of natural infection?
    NATURE MEDICINE
    
    D.R. Burton e P.W.H.I. Parren, "Vaccines and the induction of functional antibodies: Time to look beyond the molecules of natural infection?", NAT MED, 6(2), 2000, pp. 123-125
48. Tugarinov, V; Zvi, A; Levy, R; Hayek, Y; Matsushita, S; Anglister, J
    NMR structure of an anti-gp120 antibody complex with a V3 peptide reveals a surface important for co-receptor binding
    STRUCTURE WITH FOLDING & DESIGN
    
    V. Tugarinov et al., "NMR structure of an anti-gp120 antibody complex with a V3 peptide reveals a surface important for co-receptor binding", STRUCT F D, 8(4), 2000, pp. 385-395
49. Murakami, T; Yamamoto, N
    Roles of chemokines and chemokine receptors in HIV-1 infection
    INTERNATIONAL JOURNAL OF HEMATOLOGY
    
    T. Murakami e N. Yamamoto, "Roles of chemokines and chemokine receptors in HIV-1 infection", INT J HEMAT, 72(4), 2000, pp. 412-417
50. Balbach, JJ; Yang, J; Weliky, DP; Steinbach, PJ; Tugarinov, V; Anglister, J; Tycko, R
    Probing hydrogen bonds in the antibody-bound HIV-1 gp120 V3 loop by solid state NMR REDOR measurements
    JOURNAL OF BIOMOLECULAR NMR
    
    J.J. Balbach et al., "Probing hydrogen bonds in the antibody-bound HIV-1 gp120 V3 loop by solid state NMR REDOR measurements", J BIOM NMR, 16(4), 2000, pp. 313-327
51. Dolin, R
    HIV vaccines for prevention of infection and disease in humans
    INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
    
    R. Dolin, "HIV vaccines for prevention of infection and disease in humans", INF DIS CL, 14(4), 2000, pp. 1001
52. Platt, EJ; Kozak, SL; Kabat, D
    Critical role of enhanced CD4 affinity in laboratory adaptation of human immunodeficiency virus type 1
    AIDS RESEARCH AND HUMAN RETROVIRUSES
    
    E.J. Platt et al., "Critical role of enhanced CD4 affinity in laboratory adaptation of human immunodeficiency virus type 1", AIDS RES H, 16(9), 2000, pp. 871-882
53. Rizzuto, C; Sodroski, J
    Fine definition of a conserved CCR5-binding region on the human immunodeficiency virus type 1 glycoprotein 120
    AIDS RESEARCH AND HUMAN RETROVIRUSES
    
    C. Rizzuto e J. Sodroski, "Fine definition of a conserved CCR5-binding region on the human immunodeficiency virus type 1 glycoprotein 120", AIDS RES H, 16(8), 2000, pp. 741-749
54. Lee, MK; Martin, MA; Cho, MW
    Higher Western blot immunoreactivity of glycoprotein 120 from R5 HIV type 1 isolates compared with X4 and X4R5 isolates
    AIDS RESEARCH AND HUMAN RETROVIRUSES
    
    M.K. Lee et al., "Higher Western blot immunoreactivity of glycoprotein 120 from R5 HIV type 1 isolates compared with X4 and X4R5 isolates", AIDS RES H, 16(8), 2000, pp. 765-775
55. Canki, M; Sparrow, JR; Chao, W; Potash, MJ; Volsky, DJ
    Human immunodeficiency virus type 1 can infect human retinal pigment epithelial cells in culture and alter the ability of the cells to phagocytose rod outer segment membranes
    AIDS RESEARCH AND HUMAN RETROVIRUSES
    
    M. Canki et al., "Human immunodeficiency virus type 1 can infect human retinal pigment epithelial cells in culture and alter the ability of the cells to phagocytose rod outer segment membranes", AIDS RES H, 16(5), 2000, pp. 453-463
56. Momoi, Y; Ichiyama, K; Chowdhury, IH; Koyanagi, Y; Yamamoto, N
    Pertussis toxin enhances human immunodeficiency virus type 1 replication
    AIDS RESEARCH AND HUMAN RETROVIRUSES
    
    Y. Momoi et al., "Pertussis toxin enhances human immunodeficiency virus type 1 replication", AIDS RES H, 16(4), 2000, pp. 373-379
57. Nisole, S; Krust, B; Dam, E; Bianco, A; Seddiki, N; Loaec, S; Callebaut, C; Guichard, G; Muller, S; Briand, JP; Hovanessian, AG
    The HB-19 pseudopeptide S[K psi(CH2N)PR]-TASP inhibits attachment of T lymphocyte- and macrophage-tropic HIV to permissive cells
    AIDS RESEARCH AND HUMAN RETROVIRUSES
    
    S. Nisole et al., "The HB-19 pseudopeptide S[K psi(CH2N)PR]-TASP inhibits attachment of T lymphocyte- and macrophage-tropic HIV to permissive cells", AIDS RES H, 16(3), 2000, pp. 237-249
58. Bures, R; Gaitan, A; Zhu, TF; Graziosi, C; McGrath, KM; Tartaglia, J; Caudrelier, P; EL Habib, R; Klein, M; Lazzarin, A; Stablein, DM; Deers, M; Corey, L; Greenberg, ML; Schwartz, DH; Montefiori, DC
    Immunization with recombinant canarypox vectors expressing membrane-anchored glycoprotein 120 followed by glycoprotein 160 boosting fails to generateantibodies that neutralize R5 primary isolates of human immunodeficiency virus type 1
    AIDS RESEARCH AND HUMAN RETROVIRUSES
    
    R. Bures et al., "Immunization with recombinant canarypox vectors expressing membrane-anchored glycoprotein 120 followed by glycoprotein 160 boosting fails to generateantibodies that neutralize R5 primary isolates of human immunodeficiency virus type 1", AIDS RES H, 16(18), 2000, pp. 2019-2035
59. Esser, U; Speck, RF; Deen, KC; Atchison, RE; Sweet, R; Goldsmith, MA
    Molecular function of the CD4 D1 domain in coreceptor-mediated entry by HIV type 1
    AIDS RESEARCH AND HUMAN RETROVIRUSES
    
    U. Esser et al., "Molecular function of the CD4 D1 domain in coreceptor-mediated entry by HIV type 1", AIDS RES H, 16(17), 2000, pp. 1845-1854
60. Su, J; Palm, A; Wu, YP; Sandin, S; Hoglund, S; Vahlne, A
    Deletion of the GPG motif in the HIV type 1 V3 loop does not abrogate infection in all cells
    AIDS RESEARCH AND HUMAN RETROVIRUSES
    
    J. Su et al., "Deletion of the GPG motif in the HIV type 1 V3 loop does not abrogate infection in all cells", AIDS RES H, 16(1), 2000, pp. 37-48
61. Dejucq, N
    HIV-1 replication in CD4(+) T cell lines: the effects of adaptation on co-receptor use, tropism, and accessory gene function
    JOURNAL OF LEUKOCYTE BIOLOGY
    
    N. Dejucq, "HIV-1 replication in CD4(+) T cell lines: the effects of adaptation on co-receptor use, tropism, and accessory gene function", J LEUK BIOL, 68(3), 2000, pp. 331-337
62. Patton, HK; Zhou, ZH; Bubien, JK; Benveniste, EN; Benos, DJ
    gp120-induced alterations of human astrocyte function: Na+/H+ exchange, K+conductance, and glutamate flux
    AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
    
    H.K. Patton et al., "gp120-induced alterations of human astrocyte function: Na+/H+ exchange, K+conductance, and glutamate flux", AM J P-CELL, 279(3), 2000, pp. C700-C708
63. Vignoli, AL; Martini, I; Haglid, KH; Silvestroni, L; Augusti-Tocco, G; Biagioni, S
    Neuronal glycolytic pathway impairment induced by HIV envenlope glyocprotein gp120
    MOLECULAR AND CELLULAR BIOCHEMISTRY
    
    A.L. Vignoli et al., "Neuronal glycolytic pathway impairment induced by HIV envenlope glyocprotein gp120", MOL C BIOCH, 215(1-2), 2000, pp. 73-80
64. Boutet, A; Altmeyer, R; Hery, C; Tardieu, M
    Direct role of plasma membrane-expressed gp120/41 in toxicity to human astrocytes induced by HIV-1-infected macrophages
    AIDS
    
    A. Boutet et al., "Direct role of plasma membrane-expressed gp120/41 in toxicity to human astrocytes induced by HIV-1-infected macrophages", AIDS, 14(17), 2000, pp. 2687-2697
65. Collado, M; Rodriguez, D; Rodriguez, JR; Vazquez, I; Gonzalo, RM; Esteban, M
    Chimeras between the human immunodeficiency virus (HIV-1) Env and vacciniavirus immunogenic proteins p14 and p39 generate in mice broadly reactive antibodies and specific activation of CD8+T cell responses to Env
    VACCINE
    
    M. Collado et al., "Chimeras between the human immunodeficiency virus (HIV-1) Env and vacciniavirus immunogenic proteins p14 and p39 generate in mice broadly reactive antibodies and specific activation of CD8+T cell responses to Env", VACCINE, 18(27), 2000, pp. 3123-3133
66. Yang, J; Zhang, YW; Huang, JF; Zhang, YP; Liu, CQ
    Structure analysis of CCR5 from human and primates
    JOURNAL OF MOLECULAR STRUCTURE-THEOCHEM
    
    J. Yang et al., "Structure analysis of CCR5 from human and primates", J MOL ST-TH, 505, 2000, pp. 199-210
67. Charan, RD; Munro, MHG; O'Keefe, BR; Sowder, RC; McKee, TC; Currens, MJ; Pannell, LK; Boyd, MR
    Isolation and characterization of Myrianthus holstii lectin, a potent HIV-1 inhibitory protein from the plant Myrianthus holstii
    JOURNAL OF NATURAL PRODUCTS
    
    R.D. Charan et al., "Isolation and characterization of Myrianthus holstii lectin, a potent HIV-1 inhibitory protein from the plant Myrianthus holstii", J NAT PROD, 63(8), 2000, pp. 1170-1174
68. Schaeffer, DJ; Krylov, VS
    Anti-HIV activity of extracts and compounds from algae and cyanobacteria
    ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY
    
    D.J. Schaeffer e V.S. Krylov, "Anti-HIV activity of extracts and compounds from algae and cyanobacteria", ECOTOX ENV, 45(3), 2000, pp. 208-227
69. Candotti, D; Adu-Sarkodie, Y; Davies, F; Baldrich-Rubio, E; Stirrups, K; Lee, H; Allain, JP
    AIDS in an HIV-seronegative Ghanaian woman with intersubtype A/G recombinant HIV-1 infection
    JOURNAL OF MEDICAL VIROLOGY
    
    D. Candotti et al., "AIDS in an HIV-seronegative Ghanaian woman with intersubtype A/G recombinant HIV-1 infection", J MED VIROL, 62(1), 2000, pp. 1-8
70. Sprong, H; van Meer, G; van der Sluijs, P
    Analysis of galactolipids and UDP-galactose: Ceramide galactosyltransferase
    SPHINGOLIPID METABOLISM AND CELL SIGNALING, PT A
    
    H. Sprong et al., "Analysis of galactolipids and UDP-galactose: Ceramide galactosyltransferase", METH ENZYM, 311, 2000, pp. 59-73
71. Skehel, JJ; Wiley, DC
    Receptor binding and membrane fusion in virus entry: The influenza hemagglutinin
    ANNUAL REVIEW OF BIOCHEMISTRY
    
    J.J. Skehel e D.C. Wiley, "Receptor binding and membrane fusion in virus entry: The influenza hemagglutinin", ANN R BIOCH, 69, 2000, pp. 531-569
72. Kajumo, F; Thompson, DAD; Guo, Y; Dragic, T
    Entry of R5X4 and X4 human immunodeficiency virus type 1 strains is mediated by negatively charged and tyrosine residues in the amino-terminal domainand the second extracellular loop of CXCR4
    VIROLOGY
    
    F. Kajumo et al., "Entry of R5X4 and X4 human immunodeficiency virus type 1 strains is mediated by negatively charged and tyrosine residues in the amino-terminal domainand the second extracellular loop of CXCR4", VIROLOGY, 271(2), 2000, pp. 240-247
73. Martin, L; Barthe, P; Combes, O; Roumestand, C; Vita, C
    Engineering novel bioactive mini-proteins on natural scaffolds
    TETRAHEDRON
    
    L. Martin et al., "Engineering novel bioactive mini-proteins on natural scaffolds", TETRAHEDRON, 56(48), 2000, pp. 9451-9460
74. Williamson, C; Morris, L; Rybicki, E; Williamson, AL
    Designing HIV-1 subtype C vaccines for South Africa
    SOUTH AFRICAN JOURNAL OF SCIENCE
    
    C. Williamson et al., "Designing HIV-1 subtype C vaccines for South Africa", S AFR J SCI, 96(6), 2000, pp. 318-324
75. Pang, S; Yu, D; An, DS; Baldwin, GC; Xie, YM; Poon, B; Chow, YH; Park, NH; Chen, ISY
    Human immunodeficiency virus Env-independent infection of human CD4(-) cells
    JOURNAL OF VIROLOGY
    
    S. Pang et al., "Human immunodeficiency virus Env-independent infection of human CD4(-) cells", J VIROLOGY, 74(23), 2000, pp. 10994-11000
76. Singh, A; Collman, RG
    Heterogeneous spectrum of coreceptor usage among variants within a dualtropic human immunodeficiency virus type 1 primary-isolate quasispecies
    JOURNAL OF VIROLOGY
    
    A. Singh e R.G. Collman, "Heterogeneous spectrum of coreceptor usage among variants within a dualtropic human immunodeficiency virus type 1 primary-isolate quasispecies", J VIROLOGY, 74(21), 2000, pp. 10229-10235
77. Shieh, JTC; Martin, J; Baltuch, G; Malim, MH; Gonzalez-Scarano, F
    Determinants of syncytium formation in microglia by human immunodeficiencyvirus type 1. Role of the V1/V2 domains
    JOURNAL OF VIROLOGY
    
    J.T.C. Shieh et al., "Determinants of syncytium formation in microglia by human immunodeficiencyvirus type 1. Role of the V1/V2 domains", J VIROLOGY, 74(2), 2000, pp. 693-701
78. El Messaoudi, K; Thiry, LF; Liesnard, C; Van Tieghem, N; Bollen, A; Moguilevsky, N
    A human milk factor susceptible to cathepsin D inhibitors enhances human immunodeficiency virus type 1 infectivity and allows virus entry into a mammary epithelial cell line
    JOURNAL OF VIROLOGY
    
    K. El Messaoudi et al., "A human milk factor susceptible to cathepsin D inhibitors enhances human immunodeficiency virus type 1 infectivity and allows virus entry into a mammary epithelial cell line", J VIROLOGY, 74(2), 2000, pp. 1004-1007
79. Beaumont, T; Broersen, S; van Nuenen, AD; Huisman, HG; Husman, AMD; Heeney, JL; Schuitemaker, H
    Increased neutralization sensitivity and reduced replicative capacity of human immunodeficiency virus type 1 after short-term in vivo or in vitro passage through chimpanzees
    JOURNAL OF VIROLOGY
    
    T. Beaumont et al., "Increased neutralization sensitivity and reduced replicative capacity of human immunodeficiency virus type 1 after short-term in vivo or in vitro passage through chimpanzees", J VIROLOGY, 74(17), 2000, pp. 7699-7707
80. Nyambi, PN; Mbah, HA; Burda, S; Williams, C; Gorny, MK; Nadas, A; Zolla-Pazner, S
    Conserved and exposed epitopes on intact, native, primary human immunodeficiency virus type 1 virions of group M
    JOURNAL OF VIROLOGY
    
    P.N. Nyambi et al., "Conserved and exposed epitopes on intact, native, primary human immunodeficiency virus type 1 virions of group M", J VIROLOGY, 74(15), 2000, pp. 7096-7107
81. Hu, QX; Trent, JO; Tomaras, GD; Wang, ZX; Murray, JL; Conolly, SM; Navenot, JM; Barry, AP; Greenberg, ML; Peiper, SC
    Identification of ENV determinants in V3 that influence the molecular anatomy of CCR5 utilization
    JOURNAL OF MOLECULAR BIOLOGY
    
    Q.X. Hu et al., "Identification of ENV determinants in V3 that influence the molecular anatomy of CCR5 utilization", J MOL BIOL, 302(2), 2000, pp. 359-375
82. Baron, S; Poast, J; Richardson, CJ; Nguyen, D; Cloyd, M
    Oral transmission of human immunodeficiency virus by infected seminal fluid and milk: A novel mechanism
    JOURNAL OF INFECTIOUS DISEASES
    
    S. Baron et al., "Oral transmission of human immunodeficiency virus by infected seminal fluid and milk: A novel mechanism", J INFEC DIS, 181(2), 2000, pp. 498-504
83. Van Drenth, C; Jenkins, A; Ledwich, L; Ryan, TC; Mashikian, MV; Brazer, W; Center, DM; Cruikshank, WW
    Desensitization of CXC chemokine receptor 4, mediated by IL-16/CD4, is independent of p56(lck) enzymatic activity
    JOURNAL OF IMMUNOLOGY
    
    C. Van Drenth et al., "Desensitization of CXC chemokine receptor 4, mediated by IL-16/CD4, is independent of p56(lck) enzymatic activity", J IMMUNOL, 165(11), 2000, pp. 6356-6363
84. Cabezas, E; Wang, M; Parren, PWHI; Stanfield, RL; Satterthwait, AC
    A structure-based approach to a synthetic vaccine for HIV-1
    BIOCHEMISTRY
    
    E. Cabezas et al., "A structure-based approach to a synthetic vaccine for HIV-1", BIOCHEM, 39(47), 2000, pp. 14377-14391
85. Zhu, XG; Borchers, C; Bienstock, RJ; Tomer, KB
    Mass spectrometric characterization of the glycosylation pattern of HIV-gp120 expressed in CHO cells
    BIOCHEMISTRY
    
    X.G. Zhu et al., "Mass spectrometric characterization of the glycosylation pattern of HIV-gp120 expressed in CHO cells", BIOCHEM, 39(37), 2000, pp. 11194-11204
86. Zhou, W; Tomer, KB; Khaledi, MG
    Evaluation of the binding between potential anti-HIV DNA-based drugs and viral envelope glycoprotein gp120 by capillary electrophoresis with laser-induced fluorescence detection
    ANALYTICAL BIOCHEMISTRY
    
    W. Zhou et al., "Evaluation of the binding between potential anti-HIV DNA-based drugs and viral envelope glycoprotein gp120 by capillary electrophoresis with laser-induced fluorescence detection", ANALYT BIOC, 284(2), 2000, pp. 334-341
87. Ushijima, H; Perovic, S; Leuck, J; Rytik, PG; Muller, WEG; Schroder, HC
    Suppression of PrPSc- and HIV-1 gp120 induced neuronal cell death by sulfated colominic acid
    JOURNAL OF NEUROVIROLOGY
    
    H. Ushijima et al., "Suppression of PrPSc- and HIV-1 gp120 induced neuronal cell death by sulfated colominic acid", J NEUROVIRO, 5(3), 1999, pp. 289-299
88. Wang, YF; Tao, L; Mitchell, E; Bravery, C; Berlingieri, P; Armstrong, P; Vaughan, R; Underwood, J; Lehner, T
    Allo-immunization elicits CD8(+) T cell-derived chemokines, HIV suppressorfactors and resistance to HIV infection in women
    NATURE MEDICINE
    
    Y.F. Wang et al., "Allo-immunization elicits CD8(+) T cell-derived chemokines, HIV suppressorfactors and resistance to HIV infection in women", NAT MED, 5(9), 1999, pp. 1004-1009
89. Desrosiers, RC
    Strategies used by human immunodeficiency virus that allow persistent viral replication
    NATURE MEDICINE
    
    R.C. Desrosiers, "Strategies used by human immunodeficiency virus that allow persistent viral replication", NAT MED, 5(7), 1999, pp. 723-725
90. Yang, ZN; Mueser, TC; Kaufman, J; Stahl, SJ; Wingfield, PT; Hyde, CC
    The crystal structure of the SIV gp41 ectodomain at 1.47 angstrom resolution
    JOURNAL OF STRUCTURAL BIOLOGY
    
    Z.N. Yang et al., "The crystal structure of the SIV gp41 ectodomain at 1.47 angstrom resolution", J STRUCT B, 126(2), 1999, pp. 131-144
91. Stanfield, RL; Cabezas, E; Satterthwait, AC; Stura, EA; Profy, AT; Wilson, IA
    Dual conformations for the HIV-1 gp120 V3 loop in complexes with differentneutralizing Fabs
    STRUCTURE WITH FOLDING & DESIGN
    
    R.L. Stanfield et al., "Dual conformations for the HIV-1 gp120 V3 loop in complexes with differentneutralizing Fabs", STRUCT F D, 7(2), 1999, pp. 131-142
92. Verrier, F; Borman, AM; Brand, D; Girard, M
    Role of the HIV type 1 glycoprotein 120 V3 loop in determining coreceptor usage
    AIDS RESEARCH AND HUMAN RETROVIRUSES
    
    F. Verrier et al., "Role of the HIV type 1 glycoprotein 120 V3 loop in determining coreceptor usage", AIDS RES H, 15(8), 1999, pp. 731-743
93. Metlas, R; Trajkovic, D; Srdic, T; Veljkovic, V; Colombatti, A
    Human immunodeficiency virus V3 peptide-reactive antibodies are present innormal HIV-negative sera
    AIDS RESEARCH AND HUMAN RETROVIRUSES
    
    R. Metlas et al., "Human immunodeficiency virus V3 peptide-reactive antibodies are present innormal HIV-negative sera", AIDS RES H, 15(7), 1999, pp. 671-677
94. Berger, EA; Murphy, PM; Farber, JM
    Chemokine receptors as HIV-1 coreceptors: Roles in viral entry, tropism, and disease
    ANNUAL REVIEW OF IMMUNOLOGY
    
    E.A. Berger et al., "Chemokine receptors as HIV-1 coreceptors: Roles in viral entry, tropism, and disease", ANN R IMMUN, 17, 1999, pp. 657-700
95. Harada, S; Maeda, Y
    Chemically induced infection of CD4-negative HeLa cells with HIV-1
    MICROBIOLOGY AND IMMUNOLOGY
    
    S. Harada e Y. Maeda, "Chemically induced infection of CD4-negative HeLa cells with HIV-1", MICROB IMMU, 43(12), 1999, pp. 1077-1086
96. Chaplin, JW
    HIV pathogenesis: gp120 antibody complexes bind CD4 and kill T-4 cells - immunotoxin therapy should prevent the progression of HIV to AIDS
    MEDICAL HYPOTHESES
    
    J.W. Chaplin, "HIV pathogenesis: gp120 antibody complexes bind CD4 and kill T-4 cells - immunotoxin therapy should prevent the progression of HIV to AIDS", MED HYPOTH, 52(2), 1999, pp. 133-146
97. Nath, A
    Pathobiology of human immunodeficiency virus dementia
    SEMINARS IN NEUROLOGY
    
    A. Nath, "Pathobiology of human immunodeficiency virus dementia", SEM NEUROL, 19(2), 1999, pp. 113-127
98. Stott, J; Hahn, BH
    Vaccines and immunology - Overview
    AIDS
    
    J. Stott e B.H. Hahn, "Vaccines and immunology - Overview", AIDS, 13, 1999, pp. S103-S104
99. Goulder, PJR; Rowland-Jones, SL; McMichael, AJ; Walker, BD
    Anti-HIV cellular immunity: recent advances towards vaccine design
    AIDS
    
    P.J.R. Goulder et al., "Anti-HIV cellular immunity: recent advances towards vaccine design", AIDS, 13, 1999, pp. S121-S136
100. Oscherwitz, J; Gotch, FM; Cease, KB; Berzofsky, JA
     New insights and approaches regarding B- and T-cell epitopes in HIV vaccine design
     AIDS
     
     J. Oscherwitz et al., "New insights and approaches regarding B- and T-cell epitopes in HIV vaccine design", AIDS, 13, 1999, pp. S163-S174